Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration
Emerging evidence Luigi Barrea, Massimiliano Caprio, Mikiko Watanabe, Giuseppe Cammarata, Alessandra Feraco, Giovanna Muscogiuri, Ludovica Verde, Annamaria Colao, Silvia Savastano Critical Reviews in Food Science and Nutrition.2023
They also act on appetite centers in the hypothalamus, reducing hunger signals and food cravings
"We have evidence these products are potentially dangerous and can potentially lead to cancer," she says
dysregulation increases the labile iron pool, which catalyzes the Fenton reaction to generate hydroxyl radicals that initiate lipid peroxidation (27)